Physician profile
Peter Steven Winston
NPI 1447395751
$550.21
in general payments reported to CMS, 2019-2025
16 companies · $90.44 in 2025
The $90.44 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.77 · 2022: $127 · 2023: $141 · 2024: $156 · 2025: $90.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photocure INC | $93.53 | 2023-2025 | Cysview |
| Merck Sharp & Dohme LLC | $58.97 | 2022-2025 | Keytruda, Keytruda Qlex |
| Teleflex LLC | $44.06 | 2021-2022 | |
| Janssen Biotech, INC. | $41.03 | 2023-2025 | Erleada |
| Urogen Pharma, INC. | $34.94 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $34.33 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $32.52 | 2024 | Provenge |
| 180 Medical, INC. | $30.47 | 2022-2023 | |
| Urovant Sciences INC | $30.16 | 2022 | |
| Boston Scientific Corporation | $29.07 | 2024 | Ams 700 |
| Alnylam Pharmaceuticals INC. | $27.41 | 2023 | Oxlumo |
| Sun Pharmaceutical Industries INC. | $23.57 | 2023 | Yonsa |
| Calyxo, INC. | $20.43 | 2025 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $20.18 | 2023 | |
| Sumitomo Pharma America, INC. | $15.56 | 2023 | Gemtesa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $13.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Winston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.